Zevia PBC Other Share Holders Equity 2021-2024 | ZVIA
Zevia PBC other share holders equity from 2021 to 2024. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| Zevia PBC Annual Other Share Holders Equity (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| Zevia PBC Quarterly Other Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | $0 |
| 2020-12-31 | |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.150B | $0.166B |
| Zevia PBC focused on addressing health challenges resulting from excess sugar consumption by offering a portfolio of zero sugar, zero calorie, naturally sweetened beverages. Zevia PBC is based in LOS ANGELES. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $203.382B | 25.94 |
| Stryker (SYK) | United States | $148.728B | 33.52 |
| Boston Scientific (BSX) | United States | $134.855B | 38.77 |
| EssilorLuxottica (ESLOY) | France | $111.549B | 0.00 |
| Medtronic (MDT) | Ireland | $108.676B | 16.14 |
| Haleon (HLN) | United Kingdom | $43.230B | 28.09 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.368B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.464B | 19.43 |
| ResMed (RMD) | United States | $35.759B | 29.39 |
| Terumo (TRUMY) | Japan | $29.367B | 41.47 |
| Koninklijke Philips (PHG) | Netherlands | $24.796B | 18.98 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.580B | 13.74 |
| Insulet (PODD) | United States | $18.378B | 73.18 |
| Baxter (BAX) | United States | $16.844B | 10.96 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.947B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.886B | 39.63 |
| Bio-Rad Laboratories (BIO) | United States | $9.115B | 30.98 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.071B | 14.11 |
| TG Therapeutics (TGTX) | United States | $5.378B | 0.00 |
| Haemonetics (HAE) | United States | $4.291B | 20.94 |
| Prestige Consumer Healthcare (PBH) | United States | $4.157B | 20.67 |
| ICU Medical (ICUI) | United States | $4.134B | 39.36 |
| Perrigo (PRGO) | Ireland | $3.694B | 10.88 |
| Envista Holdings (NVST) | United States | $3.681B | 27.42 |
| Agios Pharmaceuticals (AGIO) | United States | $3.167B | 0.00 |
| Neogen (NEOG) | United States | $3.159B | 36.45 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.782B | 17.84 |
| QuidelOrtho (QDEL) | United States | $2.548B | 16.40 |
| LeMaitre Vascular (LMAT) | United States | $2.380B | 57.85 |
| Warby Parker (WRBY) | United States | $2.366B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.977B | 34.59 |
| AtriCure (ATRC) | United States | $1.740B | 0.00 |
| InMode (INMD) | Israel | $1.552B | 9.34 |
| AdaptHealth (AHCO) | United States | $1.331B | 9.51 |
| Curaleaf Holdings (CURLF) | Canada | $1.293B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.253B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.178B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.962B | 16.97 |
| Owens & Minor (OMI) | United States | $0.943B | 7.37 |
| National Vision Holdings (EYE) | United States | $0.910B | 30.40 |
| CeriBell (CBLL) | United States | $0.904B | 0.00 |
| Evolus (EOLS) | United States | $0.826B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.809B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.679B | 30.02 |
| Surmodics (SRDX) | United States | $0.561B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.561B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.554B | 0.00 |
| Quanterix (QTRX) | United States | $0.450B | 0.00 |
| Omeros (OMER) | United States | $0.448B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.407B | 0.00 |
| ZimVie (ZIMV) | United States | $0.379B | 31.95 |
| Valneva SE (VALN) | France | $0.359B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.339B | 32.26 |
| Biote (BTMD) | United States | $0.334B | 7.31 |
| Sanara MedTech (SMTI) | United States | $0.326B | 0.00 |
| Cerus (CERS) | United States | $0.310B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.287B | 19.25 |
| Zynex (ZYXI) | United States | $0.258B | 54.07 |
| Aurora Cannabis (ACB) | Canada | $0.236B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.224B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.219B | 15.12 |
| High Tide (HITI) | Canada | $0.215B | 89.00 |
| MacroGenics (MGNX) | United States | $0.201B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.189B | 2.67 |
| Jin Medical (ZJYL) | China | $0.166B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.164B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 98.40 |
| FitLife Brands (FTLF) | United States | $0.147B | 18.50 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Fonar (FONR) | United States | $0.104B | 11.75 |
| Quipt Home Medical (QIPT) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 23.10 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.079B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.071B | 36.67 |
| Exagen (XGN) | United States | $0.069B | 0.00 |
| Modular Medical (MODD) | United States | $0.067B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.061B | 0.00 |
| MariMed (MRMD) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.053B | 0.00 |
| Apyx Medical (APYX) | United States | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.033B | 0.00 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.83 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |